Elastic Flow-Control Stents
VascX is developing elastic flow-control stents as part of its patented platform for hemodialysis access — an endovascular flow-control option intended for high-flow AV access circuits, including high-flow fistulas, where excessive dialysis access flow contributes to cardiac burden.
For decades, endovascular stents in dialysis access have been deployed to do one thing: keep vessels open. They have treated stenosis, lined damaged segments, and preserved patency. A flow-control stent reverses that intent. Rather than maximizing flow through a narrowed segment, it is designed to introduce controlled flow into a segment that is delivering more flow than the access circuit needs.
What is an elastic flow-control stent?
An elastic flow-control stent is an endovascular device designed to introduce controlled access flow into an existing AV fistula, AV graft, or other access circuit. Conventional stents in dialysis access are typically placed to treat stenosis or maintain patency; a flow-control stent's geometry is intended instead to limit excessive access flow without occluding the access.
The elastic component is what differentiates VascX's approach. The stent is designed to flex enough to accept standard endovascular interventions, including thrombectomy, and to return to its calibrated flow-control profile afterward. The design intent is for flow-control to be a property the device adds to the access, not a constraint it imposes on the clinician.
Why high-flow fistulas matter
AV fistulas are widely considered the preferred hemodialysis access where anatomically feasible, in part because of their durability and patency. Some fistulas, however, mature to or develop dialysis access flows well above what dialysis requires. Excessive flow in a high-flow fistula is not a problem for the dialysis machine itself — but it is a continuous load on the heart.
That continuous load is associated with cardiac burden in some patients, including cardiac remodeling, pulmonary hypertension, and high-output heart failure in susceptible patients. For a deeper look at the underlying problem, see high-flow dialysis access, high-flow AV fistula, and high-output heart failure and dialysis access.
Endovascular flow-control
Endovascular flow-control refers to reducing excessive dialysis access flow through a device placed inside the vessel, delivered via the vascular system rather than through open surgical revision. An elastic flow-control stent is one example: the device is intended to limit access flow from inside the access circuit, while preserving the access for ongoing hemodialysis.
The endovascular framing matters clinically because many of the patients most likely to benefit from access flow reduction already have established access circuits. An endovascular option means flow-control can be introduced into an existing circuit without recreating the access surgically. VascX's elastic flow-control stents are investigational; the company has not yet demonstrated their clinical performance and they are not cleared or approved by the U.S. Food and Drug Administration.
Access flow reduction and cardiac burden
The case for access flow reduction rests on the relationship between continuous AV access flow and the workload imposed on the heart. Excessive AV access flow may contribute to cardiac remodeling, pulmonary hypertension, and high-output heart failure in susceptible patients. Reducing access flow, when clinically warranted, is intended to reduce that cumulative cardiac burden.
Historically, access flow reduction in fistulas has been pursued surgically — banding and similar revision procedures — once cardiac or other complications appeared. An endovascular flow-control option could shift access flow reduction earlier in the patient pathway and away from open revision, though that potential is design intent, not yet demonstrated clinical performance. VascX makes no claim that its devices are proven to treat or prevent high-output heart failure, cardiac remodeling, pulmonary hypertension, hospitalization, mortality, or access failure.
Part of the VascX patented platform
VascX's elastic flow-control stents are the platform's endovascular flow-control component, designed to introduce controlled flow into existing high-flow AV access — particularly high-flow fistulas, where the access is already mature and access flow has already become a continuous burden on the heart. Rather than treating stenosis or holding a vessel open, the stent's geometry is designed to limit access flow from inside the circuit, an option intended to allow flow-control to be introduced without recreating the access surgically. At the Vascular Access Society of the Americas (VASA), Dr. John Ross discussed the "VascX patented platform" and presented images of VascX's "elastic flow-control grafts" and "elastic flow-control stents" as graft-first and stent-first answers to the same access-flow problem.
Relationship to flow-control dialysis access
Elastic flow-control stents are part of the broader flow-control dialysis access category that VascX is building. Where elastic flow-control grafts incorporate controlled flow into a new access from the start, elastic flow-control stents introduce controlled flow into an existing access circuit. Together they are intended to make flow-control a design property of the access, rather than a reactive intervention that is only available after complications appear.
For more on the broader category and the VASA discussion, see flow-control dialysis access and the press release VascX flow-control platform highlighted at VASA.
Frequently asked questions
What is an elastic flow-control stent?
An elastic flow-control stent is an endovascular device designed to introduce controlled access flow into an existing AV fistula, AV graft, or access circuit. Unlike conventional stents that are placed to treat stenosis or maintain patency, a flow-control stent's geometry is intended to limit excessive access flow without occluding the access. The elastic element is intended to accommodate standard endovascular interventions, including thrombectomy. VascX's elastic flow-control stents are investigational and are not cleared or approved by the U.S. Food and Drug Administration.
What is a flow-control stent?
A flow-control stent is an endovascular stent whose primary design intent is to limit access flow, rather than to treat stenosis or hold a vessel open. Placed into an existing AV fistula or access circuit, a flow-control stent is intended to reduce excessive dialysis access flow while preserving the function of the access for hemodialysis.
Why do high-flow fistulas matter?
AV fistulas are widely considered the preferred hemodialysis access where anatomically feasible because of their durability and patency. Some fistulas, however, mature to or develop access flows well above what dialysis requires. Excessive flow in a high-flow fistula is associated with cardiac burden, including cardiac remodeling, pulmonary hypertension, and high-output heart failure in susceptible patients. Reducing excessive fistula flow without sacrificing the access is the goal of access flow reduction and flow-control approaches.
What is endovascular flow-control?
Endovascular flow-control refers to reducing excessive dialysis access flow through a device placed inside the vessel, rather than through open surgical revision. An elastic flow-control stent is one example: it is delivered through the vascular system into the existing access circuit and is intended to limit access flow from inside the vessel. The approach can apply to fistulas, grafts, or other access circuits where flow-control is clinically warranted.
How does access flow reduction relate to cardiac burden?
Excessive AV access flow imposes a continuous load on the heart, around the clock, for as long as the access is in place. That continuous load is associated with cardiac remodeling, pulmonary hypertension, and high-output heart failure in susceptible patients. Access flow reduction is intended to lower the volume of blood moving through the access while preserving its function for hemodialysis, with the goal of reducing the cumulative cardiac burden.
How do elastic flow-control stents relate to flow-control dialysis access?
Elastic flow-control stents are part of the broader flow-control dialysis access category. Flow-control dialysis access spans both graft and stent approaches: a flow-control graft incorporates controlled flow into a new access from the start, while a flow-control stent introduces controlled flow into an existing access circuit. Together they are intended to make flow-control a design property of the access, rather than a reactive intervention after complications appear.
Are VascX products FDA-cleared?
VascX products are currently in development and are not yet cleared or approved by the U.S. Food and Drug Administration.